Equities

Amylyx Pharmaceuticals Inc

AMLX:NSQ

Amylyx Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.88
  • Today's Change0.00 / 0.00%
  • Shares traded1.28m
  • 1 Year change-84.75%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue381220.29
OPERATING EXPENSES
Cost of revenue total252.99--
Selling, general and admin. expenses, total18812739
Depreciation/amortization------
Unusual expense(income)------
Other operating expenses, total------
Total operating expense34222483
Operating income39(201)(83)
Other, net(0.66)(0.55)(5.28)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes54(198)(88)
Provision for income taxes5.030.77--
Net income after taxes49(198)(88)
Minority interest------
Net income before extra. Items49(198)(88)
Total extraordinary items------
Net income49(198)(88)
Inc.avail. to common excl. extra. Items49(198)(88)
Inc.avail. to common incl. extra. Items49(198)(88)
EPS RECONCILIATION
Basic/primary weighted average shares675856
Basic/primary eps excl. extra items0.73(3.39)(1.56)
Basic/primary eps incl. extra items0.73(3.39)(1.56)
Dilution adjustment------
Diluted weighted average shares705856
Diluted eps excl. extra items0.70(3.39)(1.56)
Diluted eps incl. extra items0.70(3.39)(1.56)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental----0
SUPPLEMENTAL INCOME
Depreciation, supplemental1.090.490.05
Total special items------
NORMALISED INCOME
Normalized income before taxes54(198)(88)
Effect of special items on income taxes------
Income tax excluding impact of special items5.030.77--
Normalized income after tax49(198)(88)
Normalized income avail. to common49(198)(88)
Basic normalized EPS0.73(3.39)(1.56)
Diluted normalized EPS0.70(3.39)(1.56)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.